Merz Aesthetics Launches New Belotero Balance (+) With Lidocaine
BELOTERO BALANCE (+) contains a hyaluronic acid filler, designed to fill etched-in lines and wrinkles while creating a smooth, natural look and feel for filler patients.
Tag: Merz
All
Popular
All
Latest
Merz Presents Xeomin Data at Toxins 2021 Virtual Event, January 16-17
Eight accepted abstract presentations provide key updates on Xeomin (incobotulinumtoxinA).
All
Latest
Top 5 Aesthetic Trends to Watch in 2025
As 2025 begins, key trends in aesthetic medicine focus on advancements such as preservation rhinoplasty, personalized body contouring, facial optimization for the digital age, enhanced recovery techniques, and preventative treatments designed to deliver natural results and improve patient outcomes.
Radiesse Gets FDA Nod for Hands: PSP Editor Tries Hers
The FDA has approved Radiesse® for hand augmentation. PSP editor Denise Mann recounts her experience with the filler.
Read MoreTake a Quick Tour of Merz’s New North America HQ with PSP
Check out Merz’s new corporate HQ in Raleigh, NC.
Read MoreXeomin Versus Botox Study for Furrows: It’s a Draw
Xeomin and BOTOX® Cosmetic performed equally well at eradicating glabellar lines, but Xeomin may be less expensive. Could this help Merz capture more market share for its toxin?
Read MoreJune 2015 Hot Stuff
The new cellulite cure, a way for the jet set to keep their skin hydrated and more in June 2015 PSP Hot Stuff.
Read MoreBreaking Up the Band: Will Cellfina be the Procedure to Beat This Summer?
With a 94% patient-satisfaction rating at 1 year, Cellfina just may be the must-have cellulite treatment for summer 2015.
Read MoreHalftime Analysis: Primary Endpoint Met in Xeomin Versus Botox Study
Preliminary results of a head-to-head post-marketing comparison of Xeomin® and Botox® Cosmetic for the treatment of moderate-to-severe glabellar facial lines showed that both met the primary efficacy endpoint.
Read MoreLess Pain, More Gain: Radiesse® Plus Now Available
Did you hear the news? Radiesse® (+) with integral 0.3% Lidocaine (“Radiesse® Plus“) received US Food and Drug Administration (FDA) approval and is now available to US physicians.
Read More